Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXHL2500490 | YL-13027片 | YL-13027 | Tablet | Chemical Drugs(1) | New Drug Application | 2025-05-21 | Shanghai Yingli Pharmaceutical Co Ltd | view | |||
CXHL2500491 | YL-13027片 | YL-13027 | Tablet | Chemical Drugs(1) | New Drug Application | 2025-05-21 | Shanghai Yingli Pharmaceutical Co Ltd | view | |||
CXHL2400656 | YL-13027片 | YL-13027 | Tablet | Chemical Drugs(1) | New Drug Application | 2024-07-05 | Shanghai Yingli Pharmaceutical Co Ltd | view | |||
CXHL2400657 | YL-13027片 | YL-13027 | Tablet | Chemical Drugs(1) | New Drug Application | 2024-07-05 | Shanghai Yingli Pharmaceutical Co Ltd | view | |||
CXHL2101797 | YL-13027片 | YL-13027 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-12-22 | Shanghai Yingli Pharmaceutical Co Ltd | view | |||
CXHL2101796 | YL-13027片 | YL-13027 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-12-22 | Shanghai Yingli Pharmaceutical Co Ltd | view | |||
CXHL2101353 | YL-13027片 | YL-13027 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-08-03 | Shanghai Yingli Pharmaceutical Co Ltd | view | |||
CXHL2101354 | YL-13027片 | YL-13027 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-08-03 | Shanghai Yingli Pharmaceutical Co Ltd | view | |||
CXHL1800193 | YL-13027 | YL-13027 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2018-11-28 | 上海璎黎药业有限公司 | Shanghai Yingli Pharmaceutical Co Ltd | In Review | 2018-11-26 | view |
CXHL1800195 | YL-13027片 | YL-13027 | Tablet | Chemical Drugs(1) | New Drug Application | 2018-11-28 | 上海璎黎药业有限公司 | Shanghai Yingli Pharmaceutical Co Ltd | In Review | 2018-11-26 | view |
CXHL1800194 | YL-13027片 | YL-13027 | Tablet | Chemical Drugs(1) | New Drug Application | 2018-11-28 | 上海璎黎药业有限公司 | Shanghai Yingli Pharmaceutical Co Ltd | In Review | 2018-11-26 | view |